|

Idarubicin Hydrochloride Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Idarubicin hydrochloride injection, Idarubicine

Pipeline

Early 1: 1Phase 2: 2

Top Sponsors

  • Children's Hospital of Soochow University2
  • Joanna Yi1

Indications

  • Cancer3
  • Acute Myeloid Leukemia2
  • AML, Childhood2
  • Pediatric AML1
  • C-KIT Mutation1

Other2 trials

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Phase 2
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Phase 2

Houston, Texas1 trial

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Texas Children's Cancer and Hematology Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.